HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors.

AbstractOBJECTIVE:
Anti-inhibin alpha and inhibin/activin betaA subunit and anti-CD99 monoclonal antibodies (mAbs) have recently been demonstrated to be able to label ovarian granulosa cells; thus, they may be of value in the diagnosis of granulosa cell tumors. The present study aimed to determine what combination of these mAbs may be useful for the differential diagnosis of sex cord-stromal tumors of ovary.
DESIGN:
Immunohistochemical analyses with anti-inhibin alpha and inhibin/activin betaA subunit antibody and anti-CD99 mAb were performed on 42 ovarian tumors, including sex cord-stromal tumors (29), ovarian epithelial cancers (10), and Krukenberg tumors (3).
RESULTS:
All sex cord-stromal tumors were positive for inhibin alpha subunit, and 17 cases (58.6%) of sex cord-stromal tumors were immunoreactive for inhibin/activin betaA subunit. Epithelial tumors and Krukenberg tumors were all negative for inhibin/activin betaA subunit except mucinous carcinoma, which showed strong cytoplasmic immunoreactivity. All sex cord-stromal tumors except one granulosa cell tumor showed membranous staining for CD99. A case of serous carcinoma and a case of mucinous carcinoma were positive for CD99, and the remaining epithelial tumors and Krukenberg tumor were all negative for CD99.
CONCLUSIONS:
The results of immunohistochemical analysis, together with literature review, suggest that inhibin alpha subunit may be a useful diagnostic marker for sex cord-stromal tumor of the ovary. In addition, anti-CD99 antibody may be useful for the differential diagnosis between ovarian tumors. Inhibin/activin betaA subunit has a limited usefulness in the differential diagnosis of ovarian tumor because of its wider immunoreactivity for both sex cord-stromal tumors and mucinous carcinomas. The differential diagnosis of sex cord-stromal tumors of the ovary would be better made with a combined use of both anti-inhibin alpha subunit and anti-CD99 mAbs.
AuthorsY L Choi, H S Kim, G Ahn
JournalArchives of pathology & laboratory medicine (Arch Pathol Lab Med) Vol. 124 Issue 4 Pg. 563-9 (Apr 2000) ISSN: 0003-9985 [Print] United States
PMID10747314 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 12E7 Antigen
  • Antibodies, Monoclonal
  • Antigens, CD
  • CD99 protein, human
  • Cell Adhesion Molecules
  • Peptides
  • inhibin beta A subunit
  • inhibin-alpha subunit
  • Inhibins
  • Inhibin-beta Subunits
Topics
  • 12E7 Antigen
  • Antibodies, Monoclonal
  • Antigens, CD (analysis)
  • Carcinoma (pathology)
  • Carcinoma, Endometrioid (pathology)
  • Cell Adhesion Molecules (analysis)
  • Female
  • Fibroma (pathology)
  • Granulosa Cell Tumor (pathology)
  • Humans
  • Immunohistochemistry
  • Inhibin-beta Subunits
  • Inhibins (analysis)
  • Krukenberg Tumor (pathology)
  • Leydig Cell Tumor (pathology)
  • Ovarian Neoplasms (pathology)
  • Peptides (analysis)
  • Sex Cord-Gonadal Stromal Tumors (pathology)
  • Thecoma (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: